The weekly litigation news digest is live. Subscribe now

IP Verse

Methods For Treating Dlbcl - EP3412687

The patent EP3412687 was granted to Amgen Research Munich on Mar 18, 2020. The application was filed on Oct 27, 2011 under application number EP18164175A. The patent is currently recorded with a legal status of "Revoked".

EP3412687

AMGEN RESEARCH MUNICH
Application Number
EP18164175A
Filing Date
Oct 27, 2011
Status
Revoked
Jan 24, 2025
Publication Date
Mar 18, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
JAMES POOLEDec 18, 2020CARPMAELS & RANSFORDADMISSIBLE

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0623679
DESCRIPTIONWO2004106381
DESCRIPTIONWO2005052004
DESCRIPTIONWO2007068354
DESCRIPTIONWO2008119565
DESCRIPTIONWO9954440
OPPOSITIONWO2007068354

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents